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Abstract
Accurate species-level identiﬁcation of alpha-hemolytic (viridans) streptococci (VGS) is very important for understanding their pathogenicity
and virulence. However, an extremely high level of similarity between VGS within the mitis group (S. pneumoniae, S. mitis, S. oralis and
S. pseudopneumoniae) often results in misidentiﬁcation of these organisms. Earlier, matrix-assisted laser desorption ionization–time of ﬂight
mass spectrometry (MALDI-TOF MS) has been suggested as a tool for the rapid identiﬁcation of S. pneumoniae. However, by using Biotyper
3.0 (Bruker) or Vitek MS (bioMerieux) databases, Streptococcus mitis/oralis species can be erroneously identiﬁed as S. pneumoniae.
ClinProTools 2.1 software was used for the discrimination of MALDI-TOF mass spectra of 25 S. pneumoniae isolates, 34 S. mitis and three
S. oralis. Phenotypical tests and multilocus gene typing schemes for the S. pneumoniae (http://spneumoniae.mlst.net/) and viridans
streptococci (http://viridans.emlsa.net/) were used for the identiﬁcation of isolates included in the study. The classifying model was
generated based on different algorithms (Genetic Algorithm, Supervised Neural Network and QuickClassiﬁer). In all cases, values of
sensitivity and speciﬁcity were found to be equal or close to 100%, allowing discrimination of mass spectra of different species. Three peaks
(6949, 9876 and 9975 m/z) were determined conferring the maximal statistical weight onto each model built. We ﬁnd this approach to be
promising for viridans streptococci discrimination.
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Introduction
Streptococcus pneumoniae, Streptococcus mitis, Streptococcus
pseudopneumoniae and Streptococcus oralis are closely related
species of viridans group streptococci (VGS) colonizing the
human oral cavity; however, their pathogenic properties differ
signiﬁcantly. While S. pneumoniae is a major human pathogen
associated with community-acquired pneumonia, meningitis
and otitis media, other representatives of this group are
commensals and can cause infections only when they gain
access to the blood stream or in an immunocompromized
host. Clinical laboratories must be able to accurately differen-
tiate S. pneumoniae from other VGS commonly found in clinical
samples to facilitate appropriate antimicrobial therapy.
However, conventional phenotypic methods such as colony
morphology, bile solubility and optochin susceptibility testing,
as well as commercial systems (API 20 Strep and Vitek 2;
bioMe′rieux, Marcy l’Etoile, France), do not always provide
accurate identiﬁcation [1–4].
A variety of genes have been used as targets for a
PCR-based discrimination of VGS: pneumolysin (ply) [5],
autolysin (lytA) [6], pneumococcal surface antigen A (psaA)
[7], and the DNA fragment of unknown function Spn9802 [8].
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However, the application of this strategy is complicated by the
reports that Streptococcus mitis and Streptococcus oralis harbour
the genes encoding autolysin and pneumolysin [9–11].
Sequence analysis of 16S rRNA genes also cannot be applied
for discrimination of VGS due to 99% similarity in nucleotide
composition of 16S rRNA genes in these bacteria [12,13].
Sequence analysis of rnpB (RNA subunit of endonuclease P),
sodA (manganese-dependent superoxide dismutase), tuf
(elongation factor Tu), groESL (heat shock proteins) and rpoB
(b-subunit of bacterial RNA polymerase) genes is more
promising but the data are insufﬁcient for ﬁnal conclusions.
At present the most reliable identiﬁcation of VGS can be
achieved by using multilocus sequence analysis (MLSA) [14].
This approach is based on the construction of a phylogenetic
tree on the concatenated sequences of seven housekeeping
gene fragments and displaying the clonal relationship between
unknown strains under study and strains stored in the public
databases. Viridans.eMLSA.net allows streptococcal strains to
be assigned to species within the VGS. Correct S. pneumoniae
identiﬁcation can also be achieved using the mlst.net database,
which was designed mainly for intraspecies typing of pneumo-
cocci [15]. Unfortunately, MLSA is relatively expensive and
time-consuming.
Recently direct bacterial proﬁling by means of matrix-as-
sisted laser desorption ionization–time of ﬂight mass spec-
trometry (MALDI-TOF MS) has been suggested as a tool for
the rapid identiﬁcation of different bacteria. Unfortunately,
using the Biotyper 3.0 (Bruker Daltonics, Bremen, Germany)
database Streptococcus mitis/oralis species can be erroneously
identiﬁed as S. pneumoniae, due to the exceptional similarity of
their mass spectra [16–19].
In this study, a number of mathematical classifying algo-
rithms were applied to sort mass spectra of VGS by the
selection of a set of mass peaks discriminating phenotypically
and genetically characterized isolates of different VGS species.
From these classes, a number of classifying models were
generated and compared by the parameters of sensitivity and
speciﬁcity. Finally, successful models were blind tested on the
randomly selected S. pneumoniae and S. mitis strains.
Methods
Strains
A total of 62 VGS were included in the study. Thirty-four of
them were identiﬁed in our previous study as S. mitis and three
as S. oralis [20]. Twenty-ﬁve isolates were identiﬁed as
S. pneumoniae based on bile solubility, optochin susceptibility
and positive results of the ‘Slidex® pneumo-kit’ (bioMerieux®,
Marcy-l’Etoile, France) test. For S. pneumoniae isolates,
serotypes were determined using antisera obtained from the
Staten Serum Institute (Copenhagen, Denmark) according to
the manufacturer’s recommendations. All VGS isolates were
stored at 80°C in CRYOBANKe (Copan, Italy) vials.
Before mass spectrometry analysis and genetic studies,
isolates were subcultured on Columbia agar (Oxoid Ltd,
Basingstoke, UK) with addition of 5% sheep blood (overnight
incubation at 35°C in air with 5% CO2), and phenotypic tests
(bile solubility, optochin susceptibility and the ‘Slidex®
pneumo-kit’ test) were repeated. An optochin susceptibility
test was carried out using the standard diagnostic optochin
discs (Research Centre on Pharmacotherapy, St Petersburg,
Russia), in air with 5% CO2.
Gene analysis: MLST and MLSA schemes
For the genetic manipulations, streptococcal DNA was
extracted using the ‘DNA-express’ kit (‘Lytech’ Ltd, Moscow,
Russia), in accordance with the manufacturer’s instructions.
MLST and MLSA were performed as described by Enright and
Spratt [15] and by Bishop et al. [14], respectively. Results were
analysed using the MLST (http://www.mlst.net) and MLSA
(http://viridans.emlsa.net/) databases.
MALDI TOF data acquisition
For MALDI-TOF mass spectrometry analysis, two to three
isolated colonies of fresh bacterial cultures (18 h) were picked
up with a sterile 1.0 ll plastic loop (FL Medical, Torreglia, Italy)
and suspended in 300 lL of pure water (Fluka, St. Louis, MO,
USA). After precipitation with ethanol (900 ll), the pellet was
treated with a formic acid/acetonitrile mixture. Bacterial
extracts (1 ll) were spotted onto a MALDI sample target,
overlaid with 1 lL of the matrix (saturated solution of
alpha-cyano-4-hydroxy cinnamic acid (CHCA) in 50% aceto-
nitrile/2.5% TFA), and dried in the air. Mass spectra were
recorded on a Microﬂex MALDI-TOF mass spectrometer
(Bruker Daltonics) equipped with a N2 337 nm laser. Not less
than four mass spectra were obtained from each isolate, with a
total of 250 shots per spectrum (50 shots at each of ﬁve
different spot positions). For visual spectra inspection the
FlexAnalysis 2.4 software (Bruker Daltonics) was used.
BioTyper 3.0 software (Bruker Daltonics) was used for the
comparison and identiﬁcation of spectra.
Data processing with ClinProTools software
ClinProTools 2.1 software (Bruker Daltonics) was used for the
recognition of peptide patterns. This software was originally
provided as a part of the ClinProte system solution for
searching for biomarkers in human body ﬂuids (serum, plasma,
urine, saliva, cerebral spinal ﬂuid, etc.) associated with the
different diseases. It allows a measurement and visualization of
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peptide and protein differences in mass spectra of different
samples [21]. Spectra pretreatment, peak picking and peak
calculation operations were performed using the standard
mode. Classiﬁcation models were generated using Genetic
Algorithm (GA), Supervised Neural Network (SNN) and
QuickClassiﬁer (QC) algorithms.
For each model, recognition capability (RC), relative
number of correctly classiﬁed spectra for the given model
under the constraint that all tested data are previously used for
the determination of the model, and cross-validation (CV), a
quantitative measure for the reliability of a model that can be
used to predict how a model will behave in the future, were
calculated.
External validation was carried out on the blindly selected
isolates; the values of sensitivity and speciﬁcitywere determined.
Results
MLST and MLSA analysis
MLST was performed on 25 isolates of S. pneumoniae, 34 of
S. mitis and three of S. oralis. All S. pneumoniae isolates were
susceptible to optochin; nine of them belong to serotype 23F,
ﬁve to 6B, ﬁve to 19F, two to 18, and serotypes 14, 19A, 9L
and 35F were presented by one isolate each.
The dendrogram depicting clonal relationships between
isolates is presented in Fig. 1(a). For two S. oralis isolates, it
failed to amplify the spi gene locus, so these strains were
discarded.
Most isolates of the ‘pneumococci’ group (24 of 25) fell into
the pneumococcal cluster (Fig. 1a, on top of the picture), while
mitis and oralis isolates formed the separate (‘non-pneumo-
coccal’) cluster. For isolates of the ‘non-pneumococcal’ cluster,
alleles of all gene fragments were found to be at least one or
more per cent different from any known for pneumococcus
allele. Only one strain (43 741) of the ‘pneumococci’ group
unexpectedly fell into the ‘non-pneumococcal’ cluster. This
strain was stably optochin susceptible and serotyped as 19F.
Then we built the phylogenetic tree using ClonalFrame v. 1.1
algorithms, which allow us to take into account possible
recombinations in bacterial populations; the distribution of
strains appeared to be the same (data not shown).
Randomly selected isolates from pneumococcal (n = 13)
and from non-pneumococcal (n = 22) clusters, including two
(b)(a)
“Pneumococci” S. mis
S. pseudopneumoniae
S. pneumoniae
“Non-pneumococci”
S. oralis
* *
0.0050.005
FIG. 1. (a) Phylogenetic trees constructed on the concatenated sequences of six housekeeping gene fragments (aroE, gdh, gki, recP and spi и xpt) and
displaying the clonal relationship between the strains under study and 6497 S. pneumoniae strains stored in the S. pneumoniae/MLST database (http://
spneumoniae.mlst.net/). A dendrogram was constructed by the neighbour-joining algorithm; the evolutionary distances were computed using the
p-distance method. (b) Phylogenetic trees constructed on the concatenated sequences of seven housekeeping gene fragments (map, pﬂ, ppaC, pyk,
rpoB, sodA and tuf) and displaying the clonal relationship between the strains under study and 244 strains of the mitis group (S. mitis, S. pneumoniae,
S. pseudopneumoniae and S. oralis) stored in the eMLSA database (http://viridans.emlsa.net/). A dendrogram was constructed by a neighbour-joining
algorithm; the evolutionary distances were computed using the p-distance method. In both ﬁgures, optochin-susceptible strains are marked by red
ﬁlled circles, while optochin-resistant strains are marked by green ﬁlled circles. Red unﬁlled circles indicate the strains that were primarily
characterized as optochin susceptible, but optochin susceptibility has not been conﬁrmed for repeated tests (see Ikryannikova et al., 2011). Asterisks
indicate two S. oralis strains for which we were unable to amplify the spi locus in the MLST scheme.
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S. oralis isolates negative on the spi locus, were additionally
analysed by the MLSA scheme.
A dendrogram based on concatenated sequences of seven
housekeeping genes from isolates included in the study and
244 strains of the mitis group (S. mitis, S. pneumoniae,
S. pseudopneumoniae and S. oralis) stored in the Viridans.eM-
LSA.net database was created (Fig. 1b). All isolates from the
‘pneumococcal’ cluster as deﬁned by MLST analysis fell into the
S. pneumoniae cluster on MLSA analysis, while 21 of 22 isolates
from the ‘non-pneumococcal’ cluster, including isolate 43 741,
fell into the S. mitis group. It was one isolate from ‘non-pneu-
mococcal’ cluster, which grouped to the S. oralis branch, along
with two S. oralis isolates for which spi locus was failed to
amplify in MLST scheme (these are marked by asterisks in
Fig 1b).
Part of the isolates identiﬁed by MLSA as S. pneumoniae
(n = 13) or S. mitis (n = 21) formed the main groups for the
generating of classifying models. Three strains attributed to
S. oralis formed the ‘oralis’ group. Other isolates included in
the study (11 S. pneumoniae and 14 S. mitis) formed the
auxiliary groups for the validation of models.
Acquisition of mass spectrometry data and generating of the
classifying model
About 120 peaks with signal-to-noise ratios greater than 5
were detected between m/z 2000 and 20 000 in the mass
spectra of 62 isolates under study.
All isolates of the ‘pneumococcal’ cluster (see Fig. 1) were
identiﬁed by BioTyper sofware as S. pneumoniae with a
spectral score of  2.3. Most of the isolates of the ‘non-pneu-
mococcal’ cluster were identiﬁed as S. pneumoniae with a
score of  2.0, and some isolates were identiﬁed as S. pneu-
moniae or S. oralis, or S. pseudopneumoniae, or S. cristatus, with
scores not less than 2.0.
Three isolates of the S. oralis cluster (Fig. 2) were also
attributed to S. pneumoniae/S. oralis/S. pseudopneumoniae/
S. cristatus species.
Further, mass spectra obtained from the strains of the main
group, 13 of S. pneumoniae and 21 of S. mitis, were compared
using ClinProTools 2.1 software. A number of different
classiﬁcation models were generated using GA, SNN and
QC algorithms. RC, CV, sensitivity and speciﬁcity of the
models are presented in Table 1.
In the GA model, the number of peaks can be deﬁned by
user. Varying this parameter, we created a model in which 17
peaks gave 100% values of RC and CV (Table 1). The number
of peaks in both the other models, SNN and QC, was detected
automatically. Six peaks were determined in the SNN model
and ﬁve in the QC model. A CV value of 100% was reached for
the GA model only, while in other models it was slightly less.
Note that cross-validation is a variant of an automatic
validation during model generation: a small part of all spectra
is left out in model generation and cluster analysis, then these
spectra are classiﬁed, and the number of correct and wrong
class predictions is determined. This procedure is repeated
several times, and the correct and wrong class predictions are
accumulated for each class.
There were three peaks (6949, 9876 and 9975 m/z)
conferring the maximal statistical weights, which were found
in each model generated. Fig. 2(a) shows an example of the
peak of m/z 6949, which contributes signiﬁcantly to the species
discrimination model: one can see that this minor peak arises
in almost all S. mitis isolates mass spectra, and is absent in the
S. pneumoniae mass spectra. Two-dimensional distribution for
(a) (b)
FIG. 2. The mass peak of 6949 m/z is presented in S. mitis isolates (green line) and is not presented in S. pneumoniae isolates (a). 2D distribution
diagram for two of the three best peaks (6949 and 9975 m/z): ellipses correspond to 95% conﬁdence interval, red and green spots denote
S. pneumoniae and S. mitis strains, respectively (b).
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the two peaks (6949 and 9975 m/z) is presented in Fig. 2(b). In
accordance with this diagram, even these two peaks were
enough for the convincing discrimination of streptococcal
species. Actually, forcing only these three peaks (6949, 9876
and 9975 m/z) into a model (designated as QC-3 in Table 1)
was followed by only a minor decrease of RC and CV values
(98.40% and 98.44%, respectively).
Each of the models was evaluated blindly using 25 isolates of
the auxiliary group (11 of pneumococci and 14 of S. mitis). All
three models showed almost 100% values of sensitivity and
speciﬁcity (Table 1).
The number of S. oralis isolates (n = 3) was insufﬁcient to
create a reliable model. However, brief computations showed
that all classiﬁers were able to discriminate S. pneumoniae from
S. oralis isolates, but not S. mitis from S. oralis isolates.
Discussion
Accurate species-level identiﬁcation of VGS isolates is impor-
tant both in terms of practice and for understanding the
pathogenic mechanisms of the particular species. For mitis
group streptococci, species identiﬁcation is especially difﬁcult.
Numerous approaches utilizing the different phenotypic spe-
cies traits do not give a good sensitivity and cannot be
considered reliable.
Introduction of MALDI-TOF-based bacterial protein proﬁl-
ing signiﬁcantly improved the process of identifying microor-
ganisms in routine practice. This approach is based on the
investigation of complex mass spectra of peptides and small
proteins, which contain unique m/z ‘signatures’ for different
microorganisms due to the inherent variations in their masses,
and allowed successful identiﬁcation and discrimination of a
broad spectrum of organisms. First attempts to discriminate
VGS using the MALDI-TOF MS were promising [16,19,22], but
later it become clear that Biotyper 3.0 (Bruker) is unable to
solve the problem [17,18,23,24]. Very recently, a novel Vitek
MS (bioMerieux) system was introduced and showed relatively
good results [25].
We hypothesized that application of alternative algorithms
to the analysis of mass spectra may be more fruitful and tried
to summarize the differences in mass spectra, instead of
looking for the similarities between them. This task can be
carried out with ClinProToolse software. Previously, few
attempts at intraspecies differentiation of some microorgan-
isms using a similar approach were made. Thus, speciﬁc mass
peaks were identiﬁed as ‘clonal-identifying’ markers for two
main phylogenetic lineages, ST-1 and ST-17, of Group B
streptococcus, which are associated with major causes of
meningitis and late-onset diseases in neonates [26]. However,
no ‘clonal’ biomarker ions were identiﬁed for the other three
major STs. Mass spectrometry proﬁles followed by ClinPro-
Toolse software analysis were exploited to ﬁnd a reproducible
model able to identify the Pantone-Valentine leukocidin (PVL)
in Staphylococcus aureus strains [27]. The peak at 4448 m/z was
found to be the most relevant peak for differentiating between
PVL-producing and non-PVL-producing strains; however,
subsequent works have shown that this peak seems to be
independent of the presence of PVL [28,29]. A good example
of differentiation of cﬁA-positive (B. fragilis division I) and
cﬁA-negative (B. fragilis division II) strains using ClinProToolse
software was demonstrated in the work of Nagy et al. [30].
Our data conﬁrm that, in spite of the extraordinary
similarity of their mass spectra, there are a number of minor
mass peaks allowing us to discriminate S. pneumoniae from
S. mitis. Deﬁning an appropriate set of these peaks, we can
differentiate these species with a sensitivity and speciﬁcity
equal or close to 100%. Three mass peaks (6949, 9876 and
9975 m/z) seem to be of interest as contributing most to the
models. Note that the similar peak, 6954 m/z, was revealed as
speciﬁc for the non-pneumococcal mitis group species in the
very recently published work of Werno et al. [31] regarding
the manual inspection of VGS mass spectra. Unfortunately, we
still cannot identify proteins attributed to these peaks, using
the available methods, but it may be a challenge for future
investigations. Also, it would be extremely interesting to build
the discriminating models for all members of the mitis group
(i.e. S. pneumoniae, S. mitis, S. oralis and S. pseudopneumoniae).
Acknowledgements
This work was supported by the BRUKER Daltonic company
(Germany) and was partially supported by RFBR (research
project No. 08-04-01597-a). We would also like to thank V. A.
Karpov for the oligonucleotide primer synthesis and M. M.
Chukin and T. A. Akopian for their assistance in the sequence
instrumentation. This publication made use of the Viridans.eM-
LSA.net database (website http://viridans.emlsa.net/) and the
TABLE 1. Parameters of the classifying models generated on
the basis of different algorithms
Model
Recognition
capability Cross-validation Sensitivity,% Speciﬁcity,%
GA 100.00 100.00 100.0 98.6
SNN 100.00 98.65 100.0 100.0
QC 100.00 99.46 100.0 100.0
QC-3a 98.40 98.44 97.9 100.0
aA model generated by three peaks (6949, 9876 and 9975 m/z) conferring the
signiﬁcant weight onto the classiﬁcation.
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 1066–1071
1070 Clinical Microbiology and Infection, Volume 19 Number 11, November 2013 CMI
S. pneumoniae MLST database (website http://spneumoniae.
mlst.net/) held at the Department of Infectious Disease
Epidemiology, Imperial College, London.
Transparency Declaration
Nothing to declare.
References
1. Teles C, Smith A, Ramage G, Lang S. Identiﬁcation of clinically relevant
viridans group streptococci by phenotypic and genotypic analysis. Eur J
Clin Microbiol Infect Dis 2011; 30: 243–250.
2. Simoes A, Valente C, de Lencastre H, Sa-Leao R. Rapid identiﬁcation of
noncapsulated Streptococcus pneumoniae in nasopharyngeal samples
allowing detection of co-colonization and reevaluation of prevalence.
Diagn Microbiol Infect Dis 2011; 71: 208–216.
3. Song J-H, Baek JY. Incorrect identiﬁcation of Streptococcus pneumoniae
and its effect on antimicrobial resistance rates. Int J Antimicrob Agents
2009; 33: 93–94.
4. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.
Accuracy of phenotypic methods for identiﬁcation of Streptococcus
pneumoniae isolates included in surveillance programs. J Clin Microbiol
2008; 46: 2184–2188.
5. Toikka P, Nikkari S, Ruuskanen O, Leinonen M, Mertsola J. Pneum-
olysin PCR-based diagnosis of invasive pneumococcal infection in
children. J Clin Microbiol 1999; 37: 633–637.
6. McAvin JC, Reilly PA, Roudabush RM et al. Sensitive and speciﬁc
method for rapid identiﬁcation of Streptococcus pneumoniae using
real-time ﬂuorescence PCR. J Clin Microbiol 2001; 39: 3446–3451.
7. Morrison KE, Lake D, Crook J et al. Conﬁrmation of psaA in all 90
serotypes of Streptococcus pneumoniae by PCR and potential of this
assay for identiﬁcation and diagnosis. J Clin Microbiol 2000; 38: 434–437.
8. Suzuki N, Yuyama M, Maeda S, Ogawa H, Mashiko K, Kiyoura Y.
Genotypic identiﬁcation of presumptive Streptococcus pneumoniae by
PCR using four genes highly speciﬁc for S. pneumoniae. J Med Microbiol
2006; 55: 709–714.
9. Seki M, Yamashita Y, Torigoe H, Tsuda H, Sato S, Maeno M.
Loop-mediated isothermal ampliﬁcation method targeting the lytA gene
for detection of Streptococcus pneumoniae. J Clin Microbiol 2005; 43:
1581–1586.
10. Verhelst R, Kaijalainen T, De Baere T et al. Comparison of Five
Genotypic techniques for identiﬁcation of optochin-resistant pneumo-
coccus-like isolates. J Clin Microbiol 2005; 41: 3521–3525.
11. Whatmore AM, Efstratiou A, Pickerell AP et al. Genetic relationships
between clinical isolates of Streptococcus pneumoniae, Streptococcus
oralis, and Streptococcus mitis: characterization of “atypical” pneumo-
cocci and organisms allied to S. mitis harboring S. pneumoniae virulence
factor-encoding genes. Infect Immun 2000; 68: 1374–1382.
12. Haanpera M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K.
Identiﬁcation of alpha-hemolytic streptococci by pyrosequencing the
16S rRNA gene and by use of VITEK 2. J Clin Microbiol 2007; 45: 762–
770.
13. Arbique JC, Poyart C, Trieu-Cuot P et al. Accuracy of phenotypic and
genotypic testing for identiﬁcation of Streptococcus pneumoniae and
description of Streptococcus pseudopneumoniae sp. J Clin Microbiol 2004;
42: 4686–4696.
14. Bishop CJ, Aanensen DM, Jordan GE, Kilian M, Hanage WP, Spratt BG.
Assigning strains to bacterial species via the internet. BMC Biol 2009; 7: 3.
15. Enright MC, Spratt BG. A multilocus sequence typing scheme for
Streptococcus pneumoniae: identiﬁcation of clones associated with
serious invasive disease. Microbiology 1998; 144: 3049–3060.
16. Friedrichs C, Rodloff AC, Chhatwal GS, Schellenberger W, Eschrich K.
Rapid identiﬁcation of viridans streptococci by mass spectrometric
discrimination. J Clin Microbiol 2007; 45: 2392–2397.
17. La Scola B, Raoult D. Direct identiﬁcation of bacteria in positive blood
culture bottles by Matrix-Assisted Laser Desorption Ionisation Time--
of-Flight mass spectrometry. PLoS ONE 2009; 4: e8041.
18. Stevenson LG, Drake SK, Murray PR. Rapid identiﬁcation of bacteria in
positive blood culture broths by Matrix-Assisted Laser Desorption
Ionization–Time of Flight mass spectrometry. J Clin Microbiol 2010; 48:
444–447.
19. Ferroni A, Suarez S, Beretti J-L et al. Real-time identiﬁcation of bacteria
and Candida species in positive blood culture broths by Matrix-Assisted
Laser Desorption Ionization–Time of Flight mass spectrometry. J Clin
Microbiol 2010; 48: 1542–1548.
20. Ikryannikova LN, Lapin KN, Malakhova MV et al. Misidentiﬁcation of
alpha-hemolytic streptococci by routine tests in clinical practice. Infect
Genet Evol 2011; 11: 1709–1715.
21. Ketterlinus R, Hsieh S-Y, Teng Sh-H, Lee H, Pusch W. Fishing for
biomarkers: analyzing mass spectrometry data with the new ClinPro-
Toolse software. Biotechniques 2005; 38: S37–S40.
22. Rupf S, Breitung K, Schellenberger W, Merte K, Kneist S, Eschrich K.
Differentiation of mutans streptococci by intact cell matrixassisted
laser desorption/ionization time-of-ﬂight mass spectrometry. Oral
Microbiol Immunol 2005; 20: 267–273.
23. Risch M, Radjenovic D, Han JN, Wydler M, Nydegger U, Risch L.
Comparison of MALDI TOF with conventional identiﬁcation of
clinically relevant bacteria. Swiss Med Wkly 2010; 140: w13095.
24. Welker M, Moore ERB. Applications of whole-cell matrix-assisted
laser-desorption/ionization time-of-ﬂight mass spectrometry in sys-
tematic microbiology. Syst Appl Microbiol 2011; 34: 2–11.
25. Martiny D, Busson L, Wybo I, Haj RAE, Dediste A, Vandenberga O.
Comparison of the Microﬂex LT and Vitek MS systems for routine
identiﬁcation of bacteria by Matrix-Assisted Laser Desorption Ioniza-
tion–Time of Flight mass spectrometry J. J Clin Microbiol 2012; 50: 1313.
26. Lartigue M-F, Kostrzewa M, Salloum M et al. Rapid detection of “highly
virulent” Group B Streptococcus ST-17 and emerging ST-1 clones by
MALDI-TOF mass spectrometry. J Microbiol Methods 2011; 86: 262–265.
27. Bittar F, Ouchenane Z, Smati F, Raoult D, Rolain J-M. MALDI-TOF-MS
for rapid detection of staphylococcal Panton–Valentine leukocidin. Int J
Antimicrob Agents 2009; 34: 467–470.
28. Szabados F, Becker K, von Eiff C, Kaase M, Gatermann S. The
matrix-assisted laser desorption/ionisation time-of-ﬂight mass spec-
trometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da
are not associated with the presence of Panton-Valentine leukocidin.
Int J Med Microbiol 2011; 301: 58–63.
29. Carbonnelle E, Benito Y, Lina G, Nassif X, Vandenesch F, Laurent F.
Detection of Panton–Valentine toxin in Staphylococcus aureus by mass
spectrometry directly from colony: time has not yet come. Int J
Antimicrob Agents 2010; 36: 187–194.
30. Nagy E, Becker S, Soki J, Urban E, Kostrzewa M. Differentiation of
division I (cﬁA-negative) and division II (cﬁA-positive) Bacteroides
fragilis strains by matrix-assisted laser desorption/ionization time-of--
ﬂight mass spectrometry. J Med Microbiol 2011; 60: 1584–1590.
31. Werno AM, Christner M, Anderson TP, Murdoch DR. Differentiation
of Streptococcus pneumoniae from non-pneumococcal streptococci of
the Streptococcus mitis group by MALDI-TOF MS. J Clin Microbiol 2012;
50: 2863–2867.
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 1066–1071
CMI Ikryannikova et al. Discrimination between S. pneumoniae and S. mitis 1071
